Kaiwu Capital - Investor Profile and Portfolio

Linekong is a Chinese online game developer and distributor. Founded in 2007 and starting with PC-based games, Linekong shifted focus to mobile games in 2013. Different from most mobile gaming businesses that start from casual games, Linekong began with mid-heavy games. Three such mobile games, Excalibur, Sword of Heaven and Blade of God, have been launched since March 2013, with the former two being developed in house. Mobile gaming contributed 83.6% of its total revenues in the first quarter of 2014. In 2012, almost all the revenues were from PC-based games. Apart from self-developed and licensed games, Linekong also offers advertising/marketing and other game-related services, such as OKSDK that is for third-party games to publish games on Linekong’s platform 8864.com. The company has partnered with some 200 Chinese channels, app stores, smartphone brands and telecom operators, to promote self-developed and licensed games.

Crown Bioscience develops drugs for cancer and CVMD (Cardiovascular and Metabolic Diseases). The company’s proprietary platform includes HuPrime that is a patient-derived xenograft (PDX) models which can be used for efficacy testing. It also offers oncology services, such as oncology databases, ex vivo services, human surrogate trials, in vitro and in vivo services, preclinical models (PDX, Humanized and Murine efficacy/PD) for CAR-T Therapy Evaluation (immuno-oncology) etc., CrownBio also has a variety of rodent and mouse models for the development of drugs for CVMD. The company also offers products, such as antibodies for in vivo and in-vitro studies, tissues for CVMD research, tumor samples for Oncology R&D, cytokines and growth factors for use in basic and preclinical research, recombinant proteins and cell lines for biological studies, immune checkpoint antibodies and tumor tissue microarrays. CrownBio has strategic partnerships with Xstrahl, a designer, and manufacturer of X-Ray solutions for radiation biology research and Horizon Discovery, a provider of advanced research tools and services for the development of personalized medicines. CrownBio acquired PreClinOmics, an in vivo preclinical company specializing in CVMD and renal disease research. The company has spun-off CBT pharmacueticals, an emerging life science oncology company.

Bossa Nova Robotics provides in-store mobile information dispensing robots that can move autonomously around the stores. The company's robot leverages artificial intelligence and big data techniques to automate the collection and analysis of on-shelf inventory data by monitoring product stock, thereby helping retail companies to keep track of the inventory on their shelve. The robots are capable of scanning products on the shelves to ascertain the levels of inventory and help consumers in locating the shelves of particular products. It is equipped with a range of sensors to avoid bumping into things and humans.

Avegant develops hardware and software-based light field technology solutions. The company has developed a new mixed reality platform which will enable companies to develop products using their technology. Features include refining concepts with visual models, transform 2D models and sketches into 3D assets, create blueprints and schematics for structures, systems etc, collaborate with other engineers and team members, etc. Additionally, the company also develops video headsets. Its product Glyph is a virtual retinal display device, which can also be used as a headphone, which projects light onto the eyes of the user instead of an LCD screen. Applications include healthcare and communication.